• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Merck scores a new Zerbaxa indication

    FIERCE PHARMA

    Merck set to seek EU, US approval of Zerbaxa for pneumonia

    FIRST WORD PHARMA

    Merck heralds a rare Big Pharma success for antibiotic PhIII, but..

    ENDPTS

    Kaleido Biosciences Emerges From Stealth Mode With $65 Million

    BIOSPACE

    Generics set to undercut blockbusters from Merck, Novartis and Bristol-Myers

    FIERCE PHARMA

    Amplyx Pharmaceuticals Appoints Ciara Kennedy, Ph.D., as President and CEO

    PR NEWSWIRE

    Magenta Bags $48.5M & Will be Helmed by Former GlaxoSmithKline R&D Head

    BIOSPACE

    Merck lines up for a quick approval with its C. diff therapy

    FIERCE BIOTECH

    Behind-the-scenes at Cards Against Biotechnology, Cubist`s snarky `last hurrah`

    FIERCE PHARMA MARKETING

    Teva wagers up to $410M on Heptares` migraine program

    FIERCE BIOTECH

    Merck may appeal to Supreme Court after losing fight to protect Cubicin patents

    FIERCE PHARMA

    Merck beats Wall Street`s expectations with a patchwork of efforts

    FIERCE PHARMA

    Merck, New England Patriots Boss Bet $30M On Antibiotics Startup Spero

    FORBES

    Pharma should pay into antibiotic resistance fund

    PM LIVE

    Merck Announces Publication of Pivotal Data from Phase 3 Clinical Studies of ZERBAXA™ (Ceftolozane/Tazobactam) in The Lancet and Clinical Infectious Diseases

    MERCK

    Merck`s Frazier joins top-paid pharma CEOs with a $25M package

    FIERCE PHARMA

    EXCLUSIVE: Shire (SHPGY) Buyout of BioMarin (BMRN) "Seems Obvious," Source Close to the Deal Tells BioSpace (DHX)

    BIOSPACE

    Cubist`s Sivextro (Tedizolid Phosphate) Approved in Europe For Bacterial Infections

    EMA

    What Does Merck`s $10B Buyback Plan Say About Pharma M&A?

    FIERCE PHARMA

    Daiichi Shells Out $200M-Plus to Help AstraZeneca Launch Movantik

    FIERCE PHARMA

    Struggling Glaxosmithkline Warns Of 150 R&D Job Cuts In Philadelphia

    FIERCE BIOTECH

    The Silver Lining In Big Pharma Layoffs And Site Closures? A Redistribution of Talent And Resources

    FORBES

    Layoffs at Cubist Come Amid a Steady Flow of Senior Execs Out of Merck

    BIOFLASH

    Merck Losing `Breakthrough` Tag for Hep C Treatment but Earnings Hit the Mark

    FIERCE PHARMA

    Antibiotics Firm Motif Bio to Tap UK Market For Cash

    REUTERS

    Singapore`s Merlion Eyes Partner for Phase III of Finafloxacin Urinary Infection Trials

    FIERCE BIOTECH

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.